TCG Crossover, a Palo Alto, CA- and NYC-based life sciences-focused investment firm with a flexible mandate to invest in both private and public companies, closed its second fund, TCGX Fund II, with $1B in capital.
The fund received support from new and existing limited partners with commitments coming globally from investors in North America, Europe, the Middle East, and Asia.
Read more on VCWire.tech, our new website dedicated to the tech venture capital industry.
FinSMEs
05/01/2023